RS71304A - Microlia inhibitors for iterrupting immune reactions inducted by interleukin 12 and ifn$(g) - Google Patents
Microlia inhibitors for iterrupting immune reactions inducted by interleukin 12 and ifn$(g)Info
- Publication number
- RS71304A RS71304A YU71304A YUP71304A RS71304A RS 71304 A RS71304 A RS 71304A YU 71304 A YU71304 A YU 71304A YU P71304 A YUP71304 A YU P71304A RS 71304 A RS71304 A RS 71304A
- Authority
- RS
- Serbia
- Prior art keywords
- inhibitors
- microlia
- iterrupting
- inducted
- ifn
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10207843A DE10207843A1 (de) | 2002-02-15 | 2002-02-15 | Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen |
| PCT/EP2003/000467 WO2003068225A1 (de) | 2002-02-15 | 2003-01-17 | Mikroglia-inhibitoren zur unterbrechung von interleukin 12 und ifn-gamma vermittelten immunreaktionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS71304A true RS71304A (en) | 2006-10-27 |
Family
ID=27674912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU71304A RS71304A (en) | 2002-02-15 | 2003-01-17 | Microlia inhibitors for iterrupting immune reactions inducted by interleukin 12 and ifn$(g) |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1474138A1 (zh) |
| JP (1) | JP2005522447A (zh) |
| KR (1) | KR20040084909A (zh) |
| CN (1) | CN1756546A (zh) |
| AR (1) | AR039556A1 (zh) |
| AU (1) | AU2003245523A1 (zh) |
| BR (1) | BR0307706A (zh) |
| CA (1) | CA2475770A1 (zh) |
| DE (1) | DE10207843A1 (zh) |
| EC (1) | ECSP045297A (zh) |
| MX (1) | MXPA04007943A (zh) |
| NO (1) | NO20043840L (zh) |
| PE (1) | PE20030906A1 (zh) |
| PL (1) | PL371327A1 (zh) |
| RS (1) | RS71304A (zh) |
| RU (1) | RU2004127677A (zh) |
| TW (1) | TW200306823A (zh) |
| UA (1) | UA81111C2 (zh) |
| UY (1) | UY27662A1 (zh) |
| WO (1) | WO2003068225A1 (zh) |
| ZA (1) | ZA200407382B (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10207844A1 (de) * | 2002-02-15 | 2003-09-04 | Schering Ag | 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
| SI1891961T1 (sl) * | 2005-03-17 | 2010-01-29 | Proyecto Biomedicina Cima Sl | Uporaba 5'-metiltioadenozina (MTA) za preprečevanje in/ali zdravljenje avtoimunske bolezni in/ali transplantacijske zavrnitve |
| CN104428293B (zh) * | 2012-06-11 | 2018-06-08 | Ucb生物制药私人有限公司 | 调节TNFα的苯并咪唑类 |
| WO2016130501A1 (en) | 2015-02-09 | 2016-08-18 | Incyte Corporation | Aza-heteroaryl compounds as pi3k-gamma inhibitors |
| WO2017079519A1 (en) | 2015-11-06 | 2017-05-11 | Incyte Corporation | Heterocyclic compounds as pi3k-gamma inhibitors |
| MX2018007147A (es) * | 2015-12-15 | 2019-03-28 | Univ Leland Stanford Junior | Metodo para prevenir y/o tratar el daño cognitivo asociado al envejecimiento y la neuroinflamacion. |
| WO2017120194A1 (en) | 2016-01-05 | 2017-07-13 | Incyte Corporation | Pyridine and pyridimine compounds as pi3k-gamma inhibitors |
| WO2017223414A1 (en) | 2016-06-24 | 2017-12-28 | Incyte Corporation | HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS |
| HUE056615T2 (hu) | 2017-10-18 | 2022-02-28 | Incyte Corp | Tercier hidroxicsoportokkal szubsztituált kondenzált imidazol-származékok mint PI3K-gamma inhibitorok |
| AU2019336675A1 (en) | 2018-09-05 | 2021-03-25 | Incyte Corporation | Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor |
| PL3860998T3 (pl) | 2018-10-05 | 2024-06-17 | Annapurna Bio Inc. | Związki i kompozycje do leczenia schorzeń związanych z aktywnością receptora apj |
| CN112341451B (zh) * | 2019-08-09 | 2022-06-17 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| CN112341450B (zh) * | 2019-08-09 | 2022-05-17 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330959A1 (de) * | 1993-09-09 | 1995-03-16 | Schering Ag | Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| CN1301975C (zh) * | 2000-01-14 | 2007-02-28 | 舍林股份公司 | 用于治疗与小胶质细胞活化有关的疾病的1,2－二芳基苯并咪唑衍生物 |
| DE10134775A1 (de) * | 2001-07-06 | 2003-01-30 | Schering Ag | 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
| DE10135050A1 (de) * | 2001-07-09 | 2003-02-06 | Schering Ag | 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
-
2002
- 2002-02-15 DE DE10207843A patent/DE10207843A1/de not_active Ceased
-
2003
- 2003-01-17 BR BR0307706-3A patent/BR0307706A/pt not_active IP Right Cessation
- 2003-01-17 AU AU2003245523A patent/AU2003245523A1/en not_active Abandoned
- 2003-01-17 RS YU71304A patent/RS71304A/sr unknown
- 2003-01-17 WO PCT/EP2003/000467 patent/WO2003068225A1/de active Application Filing
- 2003-01-17 CA CA002475770A patent/CA2475770A1/en not_active Abandoned
- 2003-01-17 EP EP03739380A patent/EP1474138A1/de not_active Withdrawn
- 2003-01-17 CN CNA038039923A patent/CN1756546A/zh active Pending
- 2003-01-17 RU RU2004127677/15A patent/RU2004127677A/ru unknown
- 2003-01-17 KR KR10-2004-7012557A patent/KR20040084909A/ko not_active Application Discontinuation
- 2003-01-17 PL PL03371327A patent/PL371327A1/xx not_active Application Discontinuation
- 2003-01-17 JP JP2003567407A patent/JP2005522447A/ja active Pending
- 2003-01-17 MX MXPA04007943A patent/MXPA04007943A/es unknown
- 2003-01-17 UA UA20040907401A patent/UA81111C2/uk unknown
- 2003-02-03 PE PE2003000119A patent/PE20030906A1/es not_active Application Discontinuation
- 2003-02-11 UY UY27662A patent/UY27662A1/es not_active Application Discontinuation
- 2003-02-12 AR ARP030100436A patent/AR039556A1/es unknown
- 2003-02-14 TW TW092103072A patent/TW200306823A/zh unknown
-
2004
- 2004-09-14 NO NO20043840A patent/NO20043840L/no not_active Application Discontinuation
- 2004-09-14 ZA ZA200407382A patent/ZA200407382B/en unknown
- 2004-09-14 EC EC2004005297A patent/ECSP045297A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR039556A1 (es) | 2005-02-23 |
| BR0307706A (pt) | 2005-01-11 |
| ZA200407382B (en) | 2005-09-14 |
| MXPA04007943A (es) | 2004-11-26 |
| DE10207843A1 (de) | 2003-09-04 |
| TW200306823A (en) | 2003-12-01 |
| EP1474138A1 (de) | 2004-11-10 |
| ECSP045297A (es) | 2004-10-26 |
| RU2004127677A (ru) | 2005-06-10 |
| AU2003245523A1 (en) | 2003-09-04 |
| JP2005522447A (ja) | 2005-07-28 |
| UA81111C2 (en) | 2007-12-10 |
| WO2003068225A1 (de) | 2003-08-21 |
| CN1756546A (zh) | 2006-04-05 |
| PL371327A1 (en) | 2005-06-13 |
| NO20043840L (no) | 2004-11-12 |
| KR20040084909A (ko) | 2004-10-06 |
| UY27662A1 (es) | 2003-09-30 |
| CA2475770A1 (en) | 2003-08-21 |
| PE20030906A1 (es) | 2004-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS71304A (en) | Microlia inhibitors for iterrupting immune reactions inducted by interleukin 12 and ifn$(g) | |
| MXPA03008955A (es) | Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez. | |
| NO20016007D0 (no) | Rekombinant anti-CD40-antistoff og anvendelser derav | |
| ES2151467T1 (es) | Inhibicion de la actividad de la quinasa p38 por aril-ureas. | |
| ES2155817T1 (es) | Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo. | |
| TW352384B (en) | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals | |
| HK1040493A1 (en) | Use of mammalian cytokine synthesis inhibitory factor in manufacturing a medicament. | |
| SG127739A1 (en) | Use of immuno-regulators | |
| NO20054959L (no) | Fremgangsmater for behandling av interleukin-6 relaterte sykdommer | |
| ES2154253T1 (es) | Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas. | |
| HK1030157A1 (en) | Use of consensus interferon and compositions comprising consensus interferon. | |
| PT814831E (pt) | Medicamentos para o tratamento de doencas autoimunitarias utilizando o interferao tau | |
| IT1245712B (it) | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree | |
| MY138373A (en) | Cytokine inhibitors | |
| MY111402A (en) | Novel uses of il-4 and/or il-10, and antibodies against the same | |
| TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
| ATE520669T1 (de) | 1,2-diarylbenzimidazole zur behandlung von erkrankungen die mit einer microglia-aktivierung assoziiert sind | |
| WO2003067221A3 (en) | Compositions and methods for restoring immune responsiveness in patients with immunological defects | |
| PT1390371E (pt) | Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores | |
| ATE249835T1 (de) | Immunoregulator | |
| Mizuno et al. | β2-Adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes | |
| NO932377D0 (no) | Antivirale forbindelser | |
| EP0668774A4 (en) | INTERLEUKIN RECEPTOR TARGETED MOLECULES FOR TREATING INFLAMMABLE ARTHRITIS. | |
| MX9708416A (es) | Derivados de piperazino como antagonistas de neuroquininas. | |
| AU2003265924A1 (en) | Benzimidazolones and their use as cytokine inhibitors |